GLP-1 medications, by comparison, cost $800$1,200 per month, adding up to $10,000+ yearly, making surgery more cost-effective long-term
In the U.S., about 6% of adults currently use GLP-1s, and 12% have used them in the past (2024 data) (Mozafariun 2025)
Use caution with insulin or sulfonylureas (hypoglycemia risk) and with a history of gallbladder disease or diabetic retinopathy
Many save each month, even after factoring in the cost of the medication
Limiting alcohol may improve progress
Akttyva team has validated the platform by identifying allosteric modulator compounds for MAP kinase-activated protein kinase 2 (MK2) where the new compounds are disrupting protein-protein interaction and signal transduction